HomeInsights52 Week High Stocks

Akums Drugs & Pharmaceuticals Ltd 52 Week High

Akums Drugs & Pharmaceuticals Ltd 52 Week High

stocks purchased

₹ 1.0 Cr

Volume Transacted

(Dec 11, 2024)

stocks purchased

16.4 K

Stocks Traded

(Dec 11, 2024)

Last Updated on: Dec 11, 2024

Image

Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS

YEARHIGH

₹ 1174.85

Last updated on: Dec 11, 2024

Key Highlights

  • The 52 Week HIGH of Akums Drugs & Pharmaceuticals Ltd is ₹ 1174 as of 11 Dec 24 .

Company Fundamentals for Akums Drugs & Pharmaceuticals Ltd

No data available

Market Price of Akums Drugs & Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Akums Drugs & Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 2024612.45
10 Dec 2024612.45
09 Dec 2024624.55
06 Dec 2024624.35
05 Dec 2024609.05
04 Dec 2024611.65
03 Dec 2024623.65
02 Dec 2024617.3
29 Nov 2024605.4
28 Nov 2024606.45

Asset Value vs Market Value of Akums Drugs & Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Akums Drugs & Pharmaceuticals Ltd

No data available

* All values are in crore

Akums Drugs & Pharmaceuticals Ltd News Hub

News

Akums Drugs ties up with Jagdale Inds for marketing of ready-to-drink nutritional beverages

This collaboration exclusively focuses on aseptic manufacturing and subsequent filling in ...

Read more

26 Nov 2024 12:47

News

Akums Drugs hits life high on inking pact with Caregen

Under the agreement, Akums was granted exclusive rights to sell a selection of Caregen's p...

Read more

19 Nov 2024 12:59

News

Akums Drugs & Pharmaceuticals to conduct board meeting

Akums Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company...

Read more

06 Nov 2024 15:48

News

Akums Drugs signs license & distribution agreement with Triple Hair Inc.

Akums Drugs & Pharmaceuticals has entered into a License & Distribution Agreement with Tri...

Read more

16 Oct 2024 13:12

News

Akums Drugs gains on inking distribution agreement with Triple Hair Inc.

Under the terms of the agreement, the company has been granted exclusive rights to further...

Read more

16 Oct 2024 11:33

News

Akums Drugs and Pharma reports turnaround Q1 numbers

Revenue from operations was at Rs 1,019 crore in the quarter ended 30 June 2024, up 5.06% ...

Read more

26 Aug 2024 10:50

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Akums Drugs & Pharmaceuticals Ltd

What is the significance of Akums Drugs & Pharmaceuticals Ltd reaching its 52-week high?

Akums Drugs & Pharmaceuticals Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Akums Drugs & Pharmaceuticals Ltd 52-week high?

Investors monitor Akums Drugs & Pharmaceuticals Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Akums Drugs & Pharmaceuticals Ltd a good buy when it hits its 52-week high?

Whether Akums Drugs & Pharmaceuticals Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Akums Drugs & Pharmaceuticals Ltd fundamentals.

What should I consider before investing in Akums Drugs & Pharmaceuticals Ltd at its 52-week high?

Before investing in Akums Drugs & Pharmaceuticals Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Akums Drugs & Pharmaceuticals Ltd stock price continue to rise after reaching its 52-week high?

Akums Drugs & Pharmaceuticals Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions